ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹1,624 Cr | ₹1,273 Cr | ₹1,144 Cr | ₹1,371 Cr | ₹711 Cr |
What is the latest Net Current Assets ratio of ALEMBIC PHARMACEUTICALS ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹1,624 Cr |
Mar2023 | ₹1,273 Cr |
Mar2022 | ₹1,144 Cr |
Mar2021 | ₹1,371 Cr |
Mar2020 | ₹711 Cr |
How is Net Current Assets of ALEMBIC PHARMACEUTICALS Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹1,624 Cr | 27.53 | |
Mar2023 | ₹1,273 Cr | 11.26 | |
Mar2022 | ₹1,144 Cr | -16.55 | |
Mar2021 | ₹1,371 Cr | 92.81 | |
Mar2020 | ₹711 Cr | - |
Compare Net Current Assets of peers of ALEMBIC PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC PHARMACEUTICALS | ₹19,212.7 Cr | -7.2% | -5.7% | 8.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹440,050.0 Cr | 2.7% | 0.9% | 34.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,208.0 Cr | -1.1% | 1.1% | 57.7% | Stock Analytics | |
CIPLA | ₹117,197.0 Cr | 0.6% | -1.7% | 8.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,586.0 Cr | -1.6% | -4.6% | 14.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,496.4 Cr | -0.5% | 2.5% | 36% | Stock Analytics |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC PHARMACEUTICALS | -7.2% |
-5.7% |
8.1% |
SENSEX | -0.7% |
-2.6% |
7.5% |
You may also like the below Video Courses